Synageva BioPharma Announces Completion of Merger with Trimeris, Inc.

Published: Nov 03, 2011

LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp., (“Synageva”) (NASDAQ:GEVA) a clinical stage biopharmaceutical company developing therapeutic products for rare disorders has announced that following the special meeting of shareholders on November 2, 2011, the Synageva and Trimeris, Inc. merger has closed.

Back to news